Huadong Medicine Co., Ltd (SHE:000963)
China · Delayed Price · Currency is CNY 27.26
-0.40 (-1.45%)
Aug 31, 2026, 3:04 PM CST
Huadong Medicine Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 44,004 | 43,612 | 41,906 | 40,624 | 37,715 | 34,563 |
Revenue Growth | 3.26% | 4.07% | 3.16% | 7.71% | 9.12% | 2.61% |
Gross Profit Gross Profit Growth | 13,985 | 14,103 | 13,899 | 13,156 | 12,028 | 10,595 |
Operating Income Operating Income Growth | 4,004 | 4,122 | 4,341 | 3,590 | 3,155 | 2,806 |
Net Income Net Income Growth | 3,460 | 3,414 | 3,512 | 2,839 | 2,499 | 2,302 |
Earnings Per Share EPS Growth | 1.98 | 1.95 | 2.00 | 1.62 | 1.43 | 1.32 |
EPS Growth | -4.22% | -2.84% | 23.61% | 13.47% | 8.58% | -18.37% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Medical Beauty Business Medical Beauty Business Growth | 1,399 |
Manufacturing Manufacturing Growth | 14,556 |
Intersegment Elimination Intersegment Elimination Growth | -3,235 |
Commercial Business Commercial Business Growth | 30,488 |
Total Total Growth | 43,208 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 5,605 | 5,054 | 5,276 | 4,663 | 3,996 | 4,032 |
Total Debt Total Debt Growth | 2,224 | 2,122 | 3,031 | 1,938 | 2,586 | 2,089 |
Net Cash (Debt) Net Cash Growth | 3,381 | 2,931 | 2,246 | 2,726 | 1,411 | 1,944 |
Net Cash Growth | 40.15% | 30.53% | -17.61% | 93.21% | -27.43% | 62.16% |
Net Cash Per Share Net Cash Per Share Growth | 1.93 | 1.67 | 1.28 | 1.56 | 0.81 | 1.11 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 4,288 | 4,246 | 3,749 | 3,929 | 2,382 | 3,170 |
Capital Expenditures CapEx Growth | -1,505 | -1,574 | -1,728 | -1,607 | -1,193 | -819.1 |
Free Cash Flow Free Cash Flow Growth | 2,784 | 2,671 | 2,021 | 2,323 | 1,189 | 2,351 |
Free Cash Flow Growth | 34.32% | 32.17% | -12.98% | 95.40% | -49.44% | 21.26% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 31.78% | 32.34% | 33.17% | 32.38% | 31.89% | 30.65% |
Operating Margin | 9.10% | 9.45% | 10.36% | 8.84% | 8.37% | 8.12% |
Pretax Margin | 9.17% | 9.21% | 10.26% | 8.53% | 8.04% | 8.18% |
Profit Margin | 7.86% | 7.83% | 8.38% | 6.99% | 6.63% | 6.66% |
FCF Margin | 6.33% | 6.13% | 4.82% | 5.72% | 3.15% | 6.80% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.930 | 0.930 | 0.930 | 0.580 | 0.290 | 0.290 |
Dividend Per Share Growth | 0% | 0% | 60.35% | 100.00% | 0% | 26.09% |
Dividend Yield | 3.11% | 2.41% | 2.80% | 1.51% | 0.67% | 0.79% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 13.98 | 20.22 | 17.24 | 25.56 | 32.85 | 30.56 |
Forward PE | 15.37 | 18.98 | 19.83 | 27.57 | 30.39 | 29.34 |
P/FCF Ratio | 17.43 | 25.84 | 29.96 | 31.24 | 69.06 | 29.92 |
PS Ratio | 1.10 | 1.58 | 1.45 | 1.79 | 2.18 | 2.04 |